Advertisement

Opening up lonely world of epileptics

3-MIN READ3-MIN
SCMP Reporter

IMAGINE waking up each day and not knowing if, without warning, your life will be disrupted. It could happen in a business meeting, while you're pouring your coffee or walking down the street.

This is what life is like for someone with epilepsy. While treatment helps 60 per cent, the remaining 40 per cent may only respond partially, or not at all, to therapy.

Epileptics are often shunned, and have been neglected by the medical profession, according to a Danish consultant neurologist Professor Mogens Dam who visited Hongkong recently.

Advertisement

However, this trend could change with the development of new drugs for the treatment of epilepsy.

These drugs will help epileptics who are resistant to existing medication, Professor Dam said. But, researchers warn, they may not work for everybody.

Advertisement

The recent advances in anti-epileptic medication centre around modifying neuro-transmitters in the brain. A major advantage over current treatment is fewer adverse side-effects.

Advertisement
Select Voice
Select Speed
1.00x